Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypotension caused by L-dopa.

D B Calne, J Brennan, A S Spiers

    British Medical Journal
    |February 21, 1970
    PubMed
    Summary
    This summary is machine-generated.

    Levodopa (L-dopa) treatment for Parkinsonism can cause significant drops in blood pressure. This study found L-dopa reduced systolic blood pressure by 19.3 mm.Hg in patients, potentially due to dopamine's effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part I. Chronic Lymphocytic Leukemias.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part II: Chronic Granulocytic Leukemia.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    The cardiovascular effects of bromocriptine in Parkinsonism.

    British journal of clinical pharmacology·2012
    Same author

    Parkinsonism-physiology and pharmacology.

    British medical journal·2010
    Same author

    German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.

    Parkinsonism & related disorders·2008
    Same author

    The role of the Lewy body in idiopathic Parkinsonism.

    Parkinsonism & related disorders·2008
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Idiopathic Parkinsonism is a neurodegenerative disorder affecting motor control.
    • Levodopa (L-dopa) is a primary treatment for Parkinsonism, but its side effects require careful management.

    Purpose of the Study:

    • To investigate the effect of maximum tolerated doses of L-dopa on blood pressure in Parkinsonism patients.
    • To explore potential mechanisms behind L-dopa-induced hypotension.

    Main Methods:

    • Twenty patients diagnosed with idiopathic Parkinsonism were enrolled.
    • Maximum tolerated doses of L-dopa were administered.
    • Blood pressure (erect systolic) and pulse rate were monitored.

    Main Results:

    • L-dopa induced a mean reduction of 19.3 mm.Hg in erect systolic blood pressure.

    Related Experiment Videos

  • No significant changes in pulse rate were observed.
  • Hypotension was a notable side effect at therapeutic L-dopa doses.

    • Conclusions:

    • Levodopa can cause significant orthostatic hypotension in Parkinsonism patients.
    • The mechanism may involve dopamine's action on adrenergic nerve endings or the central nervous system.
    • Blood pressure monitoring is crucial during L-dopa therapy for Parkinsonism.